Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics, Icon Team on Personalized Medicine Services

NEW YORK (GenomeWeb News) – Irish drug development services firm Icon said this week that it has signed an agreement with Empire Genomics to provide personalized medicine development services.

The firms will combine Empire's expertise in pharmacogenomics and computational modeling of disease states with Icon's translational medicine capabilities, clinical trial design, and expertise in biomarkers. They said the partnership will enable the identification of populations that respond to targeted drugs, permit stratification of patients through the development and use of companion diagnostics, and streamline drug development programs.

Financial and other terms of the alliance were not disclosed.

Buffalo, NY-based Empire Genomics was founded in 2006 using research started at the Roswell Park Cancer Institute. The firm makes array-based research products, Bacterial Artificial Chromosome libraries, and FISH probes.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.